Finance

Lists
CAMX:STO
Camurus AB
၇၄၁.၀၀ SEK
+၁.၃၇%
(+၁၀.၀၀) 1D
နို ၉, GMT+၁ ၁၇:၂၉:၄၀  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CAMX...
Open
၇၂၉.၀၀ SEK
High
၇၄၁.၀၀ SEK
Low
၇၂၈.၅၀ SEK
Mkt. cap
ဋေ ၄.၄၃ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၁.၁၀ သိန်း
52-wk high
၇၄၁.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
Open
၇၂၉.၀၀ SEK
High
၇၄၁.၀၀ SEK
Low
၇၂၈.၅၀ SEK
Mkt. cap
ဋေ ၄.၄၃ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၁.၁၀ သိန်း
52-wk high
၇၄၁.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
News stories
From web sources and news partners
TOKENPOST
TOKENPOST
·
ပြီးခဲ့သည့် ၂ ရက်
Camurus Posts 28% Q3 Revenue Growth to SEK 724 Million
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap. Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees၃၁၆
Founded၁၉၉၁
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၄၆.၄၅ ကုဋေ
၅၃.၃၁ ကုဋေ
၇၀.၂၁ ကုဋေ
၇၂.၄၀ ကုဋေ
Cost of goods sold
၃.၆၄ ကုဋေ
၃.၇၂ ကုဋေ
၄.၄၁ ကုဋေ
၄.၆၄ ကုဋေ
Cost of revenue
၃.၆၄ ကုဋေ
၃.၇၂ ကုဋေ
၄.၄၁ ကုဋေ
၄.၆၄ ကုဋေ
Research and development expenses
၁၂.၄၉ ကုဋေ
၁၃.၇၆ ကုဋေ
၁၂.၅၂ ကုဋေ
၁၄.၁၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၈.၄၅ ကုဋေ
၁၇.၇၅ ကုဋေ
၂၃.၂၃ ကုဋေ
၂၀.၅၁ ကုဋေ
Operating expense
၃၀.၄၁ ကုဋေ
၃၂.၇၅ ကုဋေ
၃၆.၅၄ ကုဋေ
၃၅.၅၇ ကုဋေ
Total operating expenses
၃၄.၀၄ ကုဋေ
၃၆.၄၇ ကုဋေ
၄၀.၉၆ ကုဋေ
၄၀.၂၁ ကုဋေ
Operating income
၁၂.၄၀ ကုဋေ
၁၆.၈၄ ကုဋေ
၂၉.၂၅ ကုဋေ
၃၂.၁၉ ကုဋေ
Other non operating income
-၁.၇၀ သောင်း
-
-
၂.၀၁ ကုဋေ
EBT including unusual items
၁၂.၆၈ ကုဋေ
၁၈.၃၉ ကုဋေ
၃၀.၉၇ ကုဋေ
၃၄.၀၅ ကုဋေ
EBT excluding unusual items
၁၂.၆၈ ကုဋေ
၁၈.၃၉ ကုဋေ
၃၀.၉၇ ကုဋေ
၃၄.၀၅ ကုဋေ
Income tax expense
၂.၆၀ ကုဋေ
၄.၀၀ ကုဋေ
၆.၈၉ ကုဋေ
၇.၀၆ ကုဋေ
Effective tax rate
၂၀.၄၇%
၂၁.၇၈%
၂၂.၂၃%
၂၀.၇၂%
Other operating expenses
-၅.၃၆ သန်း
၁.၂၄ ကုဋေ
၇.၉၅ သန်း
၈.၇၁ သန်း
Net income
၁၀.၀၉ ကုဋေ
၁၄.၃၈ ကုဋေ
၂၄.၀၈ ကုဋေ
၂၇.၀၀ ကုဋေ
Net profit margin
၂၁.၇၂%
၂၆.၉၈%
၃၄.၃၀%
၃၇.၂၉%
Earnings per share
၁.၆၇
၂.၄၀
၄.၀၅
၄.၅၃
Interest and investment income
၁.၅၅ ကုဋေ
၁.၆၉ ကုဋေ
၁.၈၆ ကုဋေ
-
Interest expense
-၁.၄၆ သန်း
-၁.၄၇ သန်း
-၁.၄၂ သန်း
-၁.၄၇ သန်း
Net interest expenses
၁.၄၁ ကုဋေ
၁.၅၅ ကုဋေ
၁.၇၂ ကုဋေ
-၁.၄၇ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၃.၀၇ ကုဋေ
၁၇.၅၃ ကုဋေ
၂၉.၉၆ ကုဋေ
၃၂.၉၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ